Medical News Today |
-
New Data Show Efficacy Of Zebinix(TM) In The Treatment Of Epilepsy -
Thu, 25 Sep 2008
Novel Treatment Also Demonstrated Significant Improvement in Quality of Life and Reduction in Depr......
-
IBE And UCB Launch New Journalism Award To Improve Understanding Of Epilepsy Around The World -
Tue, 23 Sep 2008
The International Bureau for Epilepsy (IBE) in partnership with UCB, launched a new Journalism Award......
-
Epilepsy In Later Life Conference, Scotland -
Wed, 17 Sep 2008
Guiding good practice for epilepsy in later life Older people who develop epilepsy will have bett......
-
Keppra XR(TM) Approved In The U.S. As Add-On To Other Antiepileptic Treatments For People With Partial Onset Seizures -
Mon, 15 Sep 2008
UCB announced that the U.S. Food and Drug Administration (FDA) has approved Keppra XR(TM) (levetirac......
-
New Epilepsy Campaign Promotes Healthy Mums And Babies, UK -
Thu, 11 Sep 2008
Every year, around four women with epilepsy die during pregnancy or giving birth, meaning they face ......
-
The First Direct Structural Evidence Of SV2A Has Been Revealed Thanks To Protein Tomography(TM), And Published In BBRC -
Wed, 10 Sep 2008
Sidec AB has together with UCB published the first direct structural evidence of the molecular mec......
-
Epileptic Spasms In Infants May Be Eliminated By Diet -
Wed, 10 Sep 2008
Infantile spasms are a severe and potentially devastating epilepsy condition affecting children aged......
-
Dangerous Side-Effects Of Epilepsy Drugs Reduced In New Research -
Mon, 08 Sep 2008
A breakthrough method has been found to reduce the dangerous side-effects of a medicine that suc......
-
3T MRI Leads To Better Diagnosis For Focal Epilepsy -
Sat, 06 Sep 2008
3T MRI is better at detecting and characterizing structural brain abnormalities in patients with foc......
-
Vimpat(R) Approved In Europe - First New Epilepsy Treatment For Partial-Onset Seizures In Three Years -
Wed, 03 Sep 2008
UCB announced that the European Commission (EC) has approved VimpatŪ (lacosamide) as adjunctive ther......
|
|
